Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 12.22% and Operating profit at 9.53% over the last 5 years
Flat results in Sep 25
With ROE of 15.5, it has a Very Expensive valuation with a 5.3 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 1,446 Cr (Small Cap)
34.00
21
1.52%
0.08
15.48%
4.78
Total Returns (Price + Dividend) 
Latest dividend: 1.5 per share ex-dividend date: Nov-14-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Closure of Trading Window
27-Mar-2026 | Source : BSEThis is to inform you that under SEBI LODR [Prohibition of Insider Trading] Reg. 2015 and as per code of conduct for regulating and reporting of trading by insiders and fair disclosure of the co. The Trading window for dealing in securities of the co by the Directors Officers Designated Persons Insiders ( as identified in Code) and their dependents and family members shall remain closed from Wednesday April 012026 till the end of 48h after the Audited financial results of the co for the quarter and year ended March 312026 become generally available . kindly take the above information on record.
Announcement under Regulation 30 (LODR)-Investor Presentation
03-Feb-2026 | Source : BSEAs per Reg.30 SEBI-LODR as amendment from time to time our company has announced its Unaudited Financial Result [Standalone and Consolidated] for the quarter and nine month ended on 31.12.2025 approved in its Board meeting held on 02.20.2026. enclosed herewith is Investor Presentation Kindly take on record
Announcement under Regulation 30 (LODR)-Newspaper Publication
03-Feb-2026 | Source : BSEAs per Reg. 47 of LODR the company has to published unaudited financial statements [standalone and Consolidated] for the quarter and nine month ended on 31.12.2026. approved in its board meeting held on 02.02.2026 and published on 03.02.2026 in Business Standard [English] and Mumbai Lakshadweep ][Marathi] edition. please find enclosed copies and kindly take on record.
Corporate Actions 
No Upcoming Board Meetings
Vidhi Specialty Food Ingredients Ltd has declared 150% dividend, ex-date: 14 Nov 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 10 FIIs (0.1%)
Pravinamanekfamilyprivatetrust(trusteesbipinmadhavjimanekpravinabipinmanekandmihirbipinmanek) (26.03%)
Mukul Mahavir Agrawal (1.6%)
27.01%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 25.95% vs -14.69% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 17.61% vs -16.85% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -6.52% vs 9.04% in Sep 2024
Growth in half year ended Sep 2025 is 23.92% vs 8.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -5.66% vs 22.44% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 13.27% vs 21.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 28.30% vs -26.24% in Mar 2024
YoY Growth in year ended Mar 2025 is 19.07% vs -3.32% in Mar 2024